CMBT
Cmb.Tech N.V.
CMBT's fundamentals are mixed: revenue more than doubled, but its operating margin fell 8 points to 33%. Its PE of 6.1x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect earnings to fall sharply, though they disagree widely on how much.
EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
CMBT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Under pressure |
CMBT's revenue, profitability and cash flow are currently healthy, but its balance sheet is under pressure.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CMBT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 2.9x | $8.29 | -53% |
| Current | 6.1x | $17.61 | — |
| Fair | 7.7x | $22.14 | +26% |
| Forward | 9.8x | $17.61 | — |
| Expensive | 18x | $50.69 | +188% |
Historical ranges are pointers, not guarantees.
CMBT's PE is in its fair range at 6.1x, but its recent earnings include one-off gains. Analysts expect earnings to fall, which would put today's price at 9.8x next year's earnings.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
CMBT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect CMBT's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CMBT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.79 | -38% |
| Q2 2026 | $2.89 | +131% |
| Q1 2026 | $1.70 | -21% |
| Q4 2025 | $0.66 | -85% |
| Q3 2025 | $0.83 | -86% |
| Q2 2025 | $1.25 | -79% |
| Q1 2025 | $2.15 | -63% |
| Q4 2024 | $4.36 | +0.9% |
| Q3 2024 | $5.97 | +73% |
CMBT has the stronger earnings trend. Trailing diluted EPS is up 131% for CMBT versus EOSE down 224%.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
CMBT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $691.4M | +78% |
| Q1 2026 | $519.6M | +121% |
| Q4 2025 | $589M | +161% |
| Q3 2025 | $454.2M | +105% |
| Q2 2025 | $387.8M | +55% |
| Q1 2025 | $235M | -1.6% |
| Q4 2024 | $226M | -19% |
| Q3 2024 | $221.8M | -18% |
CMBT's revenue is recovering but still below its 2020 peak: $691M last quarter, up 78% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 41% | +25 points |
| Q1 2026 | 33% | -11 points |
| Q4 2025 | 28% | -33 points |
| Q3 2025 | 28% | -33 points |
| Q2 2025 | 15% | -71 points |
| Q1 2025 | 44% | +4.3 points |
| Q4 2024 | 61% | +23 points |
| Q3 2024 | 62% | +20 points |
CMBT has the edge over EOSE on profitability, with a higher operating margin.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over CMBT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was −96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
CMBT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $249.9M | +$542.3M |
| Q1 2026 | $167.4M | +$364.9M |
| Q4 2025 | $11.7M | +$322M |
| Q3 2025 | -$133.8M | +$26.4M |
| Q2 2025 | -$292.4M | -$28.1M |
| Q1 2025 | -$197.6M | -330% |
| Q4 2024 | -$310.3M | -262% |
| Q3 2024 | -$160.2M | -280% |
CMBT has the edge over EOSE on cash generation, producing positive trailing cash flow while its opponent burns cash.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: −$443M over the past year, against −$246M the year before.
CMBT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +49% | +96M shares |
| 3 years | +44% | +88.3M shares |
| 5 years | +38% | +80M shares |
| Available history | +83% | +132M shares |
CMBT has the edge over EOSE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $572,205 |
| Q3 2024 | $716,108 |
CMBT hasn't bought back shares in the past year.
EOSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +63% | +213M shares |
| 1 year | +161% | +341M shares |
| 3 years | +888% | +497M shares |
EOSE has 553M diluted shares, up 161% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CMBT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.0x | Elevated |
| Q1 2026 | 4.4x | High |
| Q4 2025 | 6.3x | High |
| Q3 2025 | 7.3x | High |
| Q2 2025 | 7.3x | High |
| Q1 2025 | 6.6x | High |
| Q4 2024 | 2.2x | Moderate |
| Q3 2024 | 2.0x | Healthy |
CMBT's net debt is about 4.0 years of its operating earnings (EBITDA), down from 7.3 years a year ago.
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CMBT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.6 | Neutral |
| Stochastic | 33.0 | Neutral |
CMBT's weekly RSI is 53 (neutral) and its Stochastic is 33 (neutral).
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CMBT PE vs Industrials Sector
| Metric | CMBT | Sector median | Relative |
|---|---|---|---|
| PE | 6.1x | 24x | 75% below |
| PE % | 45 | 58 | 13 pts below |
CMBT is trading at 6.1x earnings, a 75% discount to the Industrials sector's median of 24x, though its recent earnings include one-off gains.
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
CMBT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.5 | 4.7% below |
| 20 week MA | $17.7 | 0.5% below |
| 50 week MA | $14.8 | 19% above |
| 100 week MA | $12.2 | 45% above |
| 200 week MA | $14.3 | 23% above |
CMBT has the edge over EOSE on trend strength, trading above more of its moving averages.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
CMBT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.2 | $8.08 | -34% |
| 2021 | $8.08 | $8.81 | +9% |
| 2022 | $8.81 | $17.2 | +96% |
| 2023 | $17.2 | $17.6 | +2% |
| 2024 | $17.6 | $10.0 | -43% |
| 2025 | $10.0 | $9.70 | -3.3% |
| 2026 YTD | $9.70 | $17.6 | +82% |
CMBT has the edge over EOSE on returns for 2026, with the stronger performance.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.